{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T14:35:02Z","timestamp":1791988502758,"version":"4.4.0"},"reference-count":35,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>People experiencing homelessness have been disproportionately affected by the opioid overdose crisis. To mitigate morbidity and mortality, several office-based addiction treatment (OBAT) programs designed for this population have been established across the US, but studies have not yet evaluated their outcomes.<\/jats:p><\/jats:sec>Objective<\/jats:title>To evaluate treatment retention and mortality in an OBAT program designed specifically for individuals experiencing homelessness with opioid use disorder (OUD).<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>A retrospective cohort study was conducted in the Boston Health Care for the Homeless Program (BHCHP). Participants included all adult patients (N\u2009=\u20091467) who had 1 or more OBAT program encounter at BHCHP from January 1, 2008, to December 31, 2018. Data analysis was conducted from January 13 to December 14, 2020.<\/jats:p><\/jats:sec>Exposures<\/jats:title>Sociodemographic, clinical, and addiction treatment\u2013related characteristics were abstracted from the BHCHP electronic health record.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcome was all-cause mortality, identified by linkage to the Massachusetts Department of Public Health vital records. Multivariable Cox proportional hazards regression analyses were performed to evaluate baseline and time-varying variables associated with all-cause mortality. Secondary addiction treatment\u2013related outcomes were abstracted from the electronic health record and included (1) BHCHP OBAT program retention, (2) buprenorphine continuation and adherence verified by toxicology testing, and (3) opioid abstinence verified by toxicology testing.<\/jats:p><\/jats:sec>Results<\/jats:title>Of 1467 patients in the cohort, 1046 were men (71.3%) and 731 (49.8%) were non-Hispanic White; mean (SD) age was 42.2 (10.6) years. Continuous retention in the OBAT program was 45.2% at 1 month, 21.7% at 6 months, and 11.3% at 12 months. Continuous buprenorphine adherence was 41.5% at 1 month, 17.6% at 6 months, and 10.2% at 12 months, and continuous opioid abstinence was 28.3% at 1 month, 6.1% at 6 months, and 2.9% at 12 months. The all-cause mortality rate was 29.0 deaths per 1000 person-years, with 51.8% dying from drug overdose. Past-month OBAT program attendance was associated with lower mortality risk (adjusted hazard ratio, 0.34; 95% CI, 0.21-0.55).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>Mortality rates were high in this cohort of addiction treatment\u2013seeking homeless and unstably housed individuals with OUD. Although continuous OBAT program retention was low, past-month attendance in care was associated with reduced mortality risk. Future work should examine interventions to promote increased OBAT attendance to mitigate morbidity and mortality in this vulnerable population.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2021.0477","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T17:31:19Z","timestamp":1614879079000},"page":"e210477","source":"Crossref","is-referenced-by-count":46,"title":["Office-Based Addiction Treatment Retention and Mortality Among People Experiencing Homelessness"],"prefix":"10.1001","volume":"4","author":[{"given":"Danielle R.","family":"Fine","sequence":"first","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Lewis","sequence":"additional","affiliation":[{"name":"Institute for Research, Quality, and Policy in Homeless Health Care, Boston Health Care for the Homeless Program, Boston, Massachusetts"},{"name":"Boston University School of Public Health, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Weinstock","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Wright","sequence":"additional","affiliation":[{"name":"Institute for Research, Quality, and Policy in Homeless Health Care, Boston Health Care for the Homeless Program, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie M.","family":"Gaeta","sequence":"additional","affiliation":[{"name":"Institute for Research, Quality, and Policy in Homeless Health Care, Boston Health Care for the Homeless Program, Boston, Massachusetts"},{"name":"Section of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis P.","family":"Baggett","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, Department of Medicine, Massachusetts General Hospital, Boston"},{"name":"Harvard Medical School, Boston, Massachusetts"},{"name":"Institute for Research, Quality, and Policy in Homeless Health Care, Boston Health Care for the Homeless Program, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,3,4]]},"reference":[{"issue":"3","key":"zoi210028r1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1001\/jamainternmed.2013.1604","article-title":"Mortality among homeless adults in Boston: shifts in causes of death over a 15-year period.","volume":"173","author":"Baggett","year":"2013","journal-title":"JAMA Intern Med"},{"key":"zoi210028r2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.drugalcdep.2018.04.021","article-title":"Substance use and homelessness among emergency department patients.","volume":"188","author":"Doran","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"zoi210028r3","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2019.112585","article-title":"Association between homelessness and opioid overdose and opioid-related hospital admissions\/emergency department visits.","volume":"242","author":"Yamamoto","year":"2019","journal-title":"Soc Sci Med"},{"issue":"7","key":"zoi210028r6","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1111\/add.2010.105.issue-7","article-title":"Improving access to opiate addiction treatment for prisoners.","volume":"105","author":"Nunn","year":"2010","journal-title":"Addiction"},{"issue":"2","key":"zoi210028r7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1080\/02791072.2011.587704","article-title":"Integrating buprenorphine treatment into a public healthcare system: the San Francisco Department of Public Health\u2019s office-based Buprenorphine Pilot Program.","volume":"43","author":"Hersh","year":"2011","journal-title":"J Psychoactive Drugs"},{"issue":"2","key":"zoi210028r8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11606-006-0023-1","article-title":"Treating homeless opioid dependent patients with buprenorphine in an office-based setting.","volume":"22","author":"Alford","year":"2007","journal-title":"J Gen Intern Med"},{"issue":"3","key":"zoi210028r9","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1080\/10550887.2012.694603","article-title":"Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in New York City: the need to expand access to buprenorphine\/naloxone in marginalized populations.","volume":"31","author":"Stancliff","year":"2012","journal-title":"J Addict Dis"},{"issue":"4","key":"zoi210028r10","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1080\/10550887.2011.609808","article-title":"Attitudes toward evidence-based pharmacological treatments among community-based addiction treatment programs targeting vulnerable patient groups.","volume":"30","author":"Krull","year":"2011","journal-title":"J Addict Dis"},{"issue":"4","key":"zoi210028r11","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jsat.2013.11.002","article-title":"Mobile opioid agonist treatment and public funding expands treatment for disenfranchised opioid-dependent individuals.","volume":"46","author":"Hall","year":"2014","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"zoi210028r12","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13722-019-0149-1","article-title":"Low barrier buprenorphine treatment for persons experiencing homelessness and injecting heroin in San Francisco.","volume":"14","author":"Carter","year":"2019","journal-title":"Addict Sci Clin Pract"},{"issue":"3","key":"zoi210028r13","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1080\/08897077.2019.1635557","article-title":"Engaging an unstably housed population with low-barrier buprenorphine treatment at a syringe services program: lessons learned from Seattle, Washington.","volume":"41","author":"Hood","year":"2020","journal-title":"Subst Abus"},{"key":"zoi210028r15","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jsat.2015.06.010","article-title":"Office-based opioid treatment with buprenorphine (OBOT-B): statewide implementation of the Massachusetts Collaborative Care Model in Community Health Centers.","volume":"60","author":"LaBelle","year":"2016","journal-title":"J Subst Abuse Treat"},{"issue":"8","key":"zoi210028r17","doi-asserted-by":"publisher","first-page":"573","DOI":"10.7326\/0003-4819-147-8-200710160-00010","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"147","author":"von Elm","year":"2007","journal-title":"Ann Intern Med"},{"issue":"12","key":"zoi210028r21","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1111\/add.v111.12","article-title":"Adopting the \u201ccascade of care\u201d framework: an opportunity to close the implementation gap in addiction care?","volume":"111","author":"Soc\u00edas","year":"2016","journal-title":"Addiction"},{"issue":"1","key":"zoi210028r22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/00952990.2018.1546862","article-title":"Development of a cascade of care for responding to the opioid epidemic.","volume":"45","author":"Williams","year":"2019","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"2","key":"zoi210028r23","first-page":"229","article-title":"Homelessness and health.","volume":"164","author":"Hwang","year":"2001","journal-title":"CMAJ"},{"issue":"8","key":"zoi210028r25","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1007\/s11606-020-05779-1","article-title":"Baseline factors associated with mortality in patients who engaged in buprenorphine treatment for opioid use disorder: a cohort study.","volume":"35","author":"Fine","year":"2020","journal-title":"J Gen Intern Med"},{"key":"zoi210028r26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.drugalcdep.2015.08.037","article-title":"The impact of low-threshold methadone maintenance treatment on mortality in a Canadian setting.","volume":"156","author":"Nolan","year":"2015","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"zoi210028r27","doi-asserted-by":"publisher","first-page":"774","DOI":"10.2105\/AJPH.91.5.774","article-title":"The impact of harm-reduction\u2013based methadone treatment on mortality among heroin users.","volume":"91","author":"Langendam","year":"2001","journal-title":"Am J Public Health"},{"issue":"2","key":"zoi210028r28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/ADM.0000000000000555","article-title":"Defining low-threshold buprenorphine treatment.","volume":"14","author":"Jakubowski","year":"2020","journal-title":"J Addict Med"},{"issue":"3","key":"zoi210028r29","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.jsat.2013.10.004","article-title":"Leaving buprenorphine treatment: patients\u2019 reasons for cessation of care.","volume":"46","author":"Gryczynski","year":"2014","journal-title":"J Subst Abuse Treat"},{"issue":"5","key":"zoi210028r30","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/archinternmed.2010.541","article-title":"Collaborative care of opioid-addicted patients in primary care using buprenorphine: five-year experience.","volume":"171","author":"Alford","year":"2011","journal-title":"Arch Intern Med"},{"issue":"4","key":"zoi210028r31","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.jsat.2009.05.003","article-title":"Buprenorphine maintenance treatment in a primary care setting: outcomes at 1 year.","volume":"37","author":"Soeffing","year":"2009","journal-title":"J Subst Abuse Treat"},{"issue":"11","key":"zoi210028r32","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1111\/j.1525-1497.2005.0228.x","article-title":"Buprenorphine retention in primary care.","volume":"20","author":"Stein","year":"2005","journal-title":"J Gen Intern Med"},{"key":"zoi210028r33","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.3389\/fpsyg.2019.01052","article-title":"Lived experience in new models of care for substance use disorder: a systematic review of peer recovery support services and recovery coaching.","volume":"10","author":"Eddie","year":"2019","journal-title":"Front Psychol"},{"issue":"3","key":"zoi210028r34","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1037\/a0026511","article-title":"Development of an in-home telehealth program for outpatient veterans with substance use disorders.","volume":"10","author":"Santa Ana","year":"2013","journal-title":"Psychol Serv"},{"key":"zoi210028r35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.drugpo.2018.01.001","article-title":"Post opioid overdose outreach by public health and public safety agencies: exploration of emerging programs in Massachusetts.","volume":"54","author":"Formica","year":"2018","journal-title":"Int J Drug Policy"},{"key":"zoi210028r5","author":"Meges","year":"2014"},{"key":"zoi210028r4","unstructured":"Massachusetts Department of Public Health. An assessment of opioid-related overdoses in Massachusetts 2011-2015. Published August 2017. Accessed March 20, 2020. https:\/\/www.mass.gov\/doc\/chapter-55-data-brief-2017\/download"},{"key":"zoi210028r14","unstructured":"Boston Health Care for the Homeless Program. Accessed on February 13, 2020. https:\/\/www.bhchp.org\/"},{"key":"zoi210028r16","unstructured":"Boston Health Care for the Homeless Program. Substance use disorder services. Published 2014. Accessed February 13 2020. https:\/\/www.bhchp.org\/specialized-services\/addiction-services"},{"key":"zoi210028r18","unstructured":"National Program of Cancer Registries (NPCR). Registry Plus: Link Plus users guide. Version 2.0. Centers for Disease Control and Prevention, Cancer Division. August 2014. Accessed February 13, 2020. https:\/\/www.cdc.gov\/cancer\/npcr\/tools\/registryplus\/lp.htm"},{"key":"zoi210028r19","unstructured":"National Center for Health Statistics. National Death Index User\u2019s Guide. Centers for Disease Control and Prevention. 2013. Accessed February 13, 2020. https:\/\/www.cdc.gov\/nchs\/data\/ndi\/ndi_users_guide.pdf?"},{"key":"zoi210028r20","unstructured":"SAMHSA's Center for the Application of Prevention Technologies. Using International Classification of Diseases (ICD) codes to assess opioid-related overdose deaths. Published June 2018. Accessed February 13, 2020. https:\/\/mnprc.org\/wp-content\/uploads\/2019\/01\/using-icd-10-codes-to-assess-opioid-related-overdose-deaths.pdf"},{"key":"zoi210028r24","unstructured":"Murphy? SL, Xu? JQ, Kochanek? KD, Arias? E. Mortality in the United States, 2017. National Center for Health Statistics. NCHS Data Brief, no. 328. Published 2018. Accessed February 13, 2020. https:\/\/www.cdc.gov\/nchs\/data\/databriefs\/db328-h.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2776968\/fine_2021_oi_210028_1698770200.37968.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T16:05:24Z","timestamp":1699545924000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2776968"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,4]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.0477","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,4]]}}}